Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN102153432B reveals a metal-free cascade synthesis for alpha-trifluoromethyl-gamma-carbonyl esters, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN113292598A discloses a Rh(III)-catalyzed enantioselective synthesis of axial chiral biaryl compounds with P-stereocenters, offering significant supply chain advantages.
Patent CN109776324B reveals a novel photocatalytic route for homoallyltrifluoromethyl compounds, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN104876820B enables high-yield catalytic synthesis of aryl formate compounds. Delivers substantial cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113929605B reveals a metal-free [2,3]-rearrangement for ortho-sulfonylation. Offers mild conditions, high regioselectivity, and cost-effective API intermediate manufacturing.
Patent CN101314559B details a low-cost kinetic resolution method for aromatic chiral secondary alcohols using Boc-Proline, offering high purity for pharma intermediates.
Novel microwave-assisted method for trans-stilbene intermediates reduces costs and improves supply chain reliability for pharmaceutical manufacturing partners globally.
Patent CN110551037B details a high-efficiency iridium/chiral diphosphine system for asymmetric hydrogenation, offering superior enantioselectivity for agrochemical intermediates.
Patent CN110590823A reveals non-transition metal catalysis for borate derivatives. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable methods.
Patent CN103497082B reveals solvent-free beta-nitrostyrene synthesis using reusable acidic ionic liquids, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN101906061B reveals a green water-phase catalytic method for indole synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN114149380A reveals a novel FeCl3-catalyzed aryl migration strategy for synthesizing 2-aryl benzoxazoles, offering significant cost reduction and improved atom economy for pharmaceutical manufacturing.
Discover the novel synthesis of chiral binaphthyl-aza ligands from patent CN112142638A. Achieve high enantioselectivity with scalable, cost-effective manufacturing processes.
Patent CN113039175A reveals a scalable catalytic route for arylsulfonyl acrylonitriles, offering cost-effective and environmentally benign manufacturing solutions for global supply chains.
Novel methanol-based methylation method replaces toxic reagents. Offers high purity, green chemistry compliance, and scalable production for pharmaceutical intermediates.
Patent CN110714208B details a metal-free electrochemical route for phenanthridine derivatives, offering significant cost and purity advantages for pharmaceutical supply chains.
Patent CN115385948A discloses silicon-centered spiro-bisoxazoline ligands enabling high-yield asymmetric carbene insertion. Ideal for reliable pharmaceutical intermediate supplier needs.
Patent CN100422154C reveals a high-purity synthesis route for 3-methylquinoline-8-sulfonyl chloride, optimizing Argatroban production with superior yield and reduced isomers.
Patent CN111978219B details a novel Cu-OMS-2 catalyzed C-S coupling for diaryl sulfides. Discover cost-effective API intermediate manufacturing solutions.
Patent CN112824374B details a nickel-catalyzed asymmetric hydrogenation method for chiral amines, offering cost-effective alternatives to precious metals for pharmaceutical intermediates.